Stephen E.

Stephen E. is an experienced pharmaceutical sales professional with a diverse background in specialty drugs and account management. Currently serving as an Account Executive at Alnylam Pharmaceuticals since January 2018, Stephen focuses on the sale of mRNA drugs. Prior to this role, Stephen worked as a Specialty Sales Representative at Endo Pharmaceuticals, selling the injection drug Xiaflex, and as a Clinical Specialist at Corcept Therapeutics, where achievements included being named Clinical Specialist of the Year in 2014 while managing sales of Korlym for rare diseases. Additional experience includes managing sales at NeurogesX, Inc. and serving as a Managing Consultant at Elliott Pharmacy Consulting. Stephen holds a Bachelor's degree in Liberal Arts and Sciences from Thomas More University and an MBA in Marketing from Xavier University.